Moyamoya syndrome following childhood acute lymphoblastic leukemia
Authors:
- Akira KikuchiAKAkira Kikuchi
- On behalf of the Tokyo Children's Cancer Study Group (TCCSG)O(On behalf of the Tokyo Children's Cancer Study Group (TCCSG)
- 3 January 2007
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 48 (3) , 268-272
Abstract
Background: Long‐term survivors of childhood acute lymphoblastic leukemia (ALL) sometimes suffer from adverse long‐term sequelae. We analyzed the incidence, clinical course and prognosis of moyamoya syndrome (MoS) following childhood ALL.Procedure: A total of 1,846 ALL patients were treated with four consecutive TCCSG ALL protocols (L84‐11, L89‐12, L92‐13, and L95‐14) between 1984 and 1999. We surveyed the MoS cases among these patients in the follow‐up studies.Results: Six patients with MoS were identified: four boys and two girls whose ages ranged from 2 years and 1 month (abbreviated as “2y1m”) to 14y 1 m at diagnosis of ALL. None of the patients had central nervous system (CNS) leukemia. All six patients received prophylactic cranial irradiation with a dosage of 18 or 24 Gy. Although one patient died of brain infarction due to MoS, no leukemic relapse was observed in the group. The cumulative incidence of MoS in our series was 0.46 ± 0.02% at 8 years. Among several clinical characteristics, use of cranial irradiation was the only factor that appeared to be significantly related to the development of MoS.Conclusions: MoS occurs with increased frequency in children treated for ALL, and might be associated with cranial irradiation. Prophylactic cranial irradiation should be used cautiously in ALL patients who can be cured by other CNS‐directed therapies. Pediatr Blood Cancer 2007;48:268–272.Keywords
This publication has 22 references indexed in Scilit:
- No Advantage of Dexamethasone Over Prednisolone for the Outcome of Standard- and Intermediate-Risk Childhood Acute Lymphoblastic Leukemia in the Tokyo Children's Cancer Study Group L95-14 ProtocolJournal of Clinical Oncology, 2005
- Extended Follow-up of Long-Term Survivors of Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2003
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01Blood, 2001
- Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1998
- A Clinical Comparison of Definite Moyamoya Disease Between South Korea and JapanStroke, 1997
- Intellectual performance after presymptomatic cranial radiotherapy for leukaemia: effects of age and sex.Archives of Disease in Childhood, 1995
- Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemiaThe Lancet, 1994
- Moyamoya phenomenon after radiation for optic gliomaJournal of Neurosurgery, 1993
- Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiationThe Journal of Pediatrics, 1993
- Post-irradiation Vasculopathy of Intracranial Major Arteries in ChildrenNeurologia medico-chirurgica, 1991